Enfaport

Complete nutrition for infants with Chylothorax or LCHAD deficiency

Last Updated: Tuesday, December 26, 2017 - 19:00

Description/Indication

Enfaport is designed to meet the unique nutritional needs of infants with chylothorax or LCHAD deficiency. Enfaport balances high levels of medium-chain triglycerides (MCT) oil for easier absorption, and has DHA and ARA, important fatty acids for infant development.

Product Features:

  • Easy-to-digest 60:40 whey-to-casein ratio, patterned after mature breast milk1,*
  • 83% MCT oil for easier fat absorption
  • DHA and ARA, important nutrients also found in breast milk that promote brain and eye development2-9
  • Kosher


* Comparison based on whey-to-casein ratio of typical mature breast milk (15 days to 6 months after birth).

† % of total fat blend.

  • Nutrients
    • (Normal Dilution)

      Per 100 Calories (3.3 fl oz)

      Per 100 mL (3.3 fl oz)

      Protein, g

      3.5

      3.6

      Fat, g

      5.5

      5.6

      Linoleic acid, mg

      350

      360

      Carbohydrate, g

      10

      10.2

      Water, g

      83

      85

      Vitamins/Other Nutrients

      Vitamin A, IU

      350

      360

      Vitamin D, IU

      50

      51

      Vitamin E, IU

      4

      4.1

      Vitamin K, mcg

      12

      12.2

      Thiamin (Vitamin B1), mcg

      80

      81

      Riboflavin (Vitamin B2), mcg

      90

      92

      Vitamin B6, mcg

      68

      69

      Vitamin B12, mcg

      0.3

      0.31

      Niacin, mcg

      1000

      1020

      Folic acid (Folacin), mcg

      16

      16.3

      Pantothenic acid, mcg

      500

      510

      Biotin, mcg

      3

      3.1

      Vitamin C (Ascorbic acid), mg

      12

      12.2

      Choline, mg

      24

      24

      Inositol, mg

      17

      17.3

      Minerals

      Calcium, mg

      94

      96

      Phosphorus, mg

      52

      53

      Magnesium, mg

      8.8

      9

      Iron, mg

      1.8

      1.83

      Zinc, mg

      1

      1.02

      Manganese, mcg

      25

      25

      Copper, mcg

      75

      76

      Iodine, mcg

      15

      15.3

      Selenium, mcg

      2.8

      2.9

      Sodium, mg

      30

      31

      Potassium, mg

      115

      117

  • Nutrient Facts
    • Nutrient Density

      30 Cal/fl oz

      Protein (% Calories)

      14

      Fat (% Calories)

      46

      Carbohydrate (% Calories)

      40

      Potential Renal Solute Load (mOsm/100 Calories)10

      28

      Potential Renal Solute Load (mOsm/100 mL)10

      29

      Osmolality (mOsm/kg water)

      360

      Osmolarity (mOsm/L)

      310

      Lactose-free

      No

  • Product Forms

      Enfaportis available in ready-to-use liquid.

      When using this information, please note the following:

      Coding systems and reimbursement allowable rates vary by payer:

      • Medicare Part B uses HCPCS (Healthcare Common Procedure Coding System) to group products
      • Medicaid systems vary by state; some use HCPCS while others use NDC format code or systems of their own—contact your state provider for more information
      • Private health insurance and managed care companies may use HCPCS, NDC format code or their own system—contact your provider for more information

    • Product: Enfaport
      Item #: 129601
      Description: RTU, 30 Cal
      Unit Size: 6 fl oz bottle
      Calories/Unit: 180
      Product Yield/Unit (fl oz): 6
      Case: 24 bottles per case
      HCPCS Code: B4162
      NDC Format Code: 00087-5105-25
  • Composition
    • Ingredients: Ready to Use: Nonfat milk, water, corn syrup solids, medium chain triglycerides (MCT oil), whey protein concentrate and less than 2%: Mortierella alpina oil*, Crypthecodinium cohnii oil, soy oil, calcium carbonate, potassium chloride, magnesium chloride, magnesium phosphate, potassium phosphate, ferrous sulfate, calcium chloride, sodium chloride, zinc sulfate, cupric sulfate, manganese sulfate, potassium iodide, sodium selenite, soy lecithin, ascorbic acid, vitamin E acetate, niacinamide, calcium pantothenate, vitamin A palmitate, vitamin D3, thiamin hydrochloride, vitamin B6 hydrochloride, riboflavin, folic acid, vitamin K1, biotin, vitamin B12, choline chloride, inositol, carrageenan, mono- and diglycerides, taurine, L-carnitine.

      * A source of arachidonic acid (ARA).

      † A source of docosahexaenoic acid (DHA).

  • Potential Allergens
    • Enfaport contains milk and soy.

  • Amino Acid Composition
    • ESSENTIAL AMINO ACIDS
      mg/100 Calmg/100 g Pwd
      Histidine88
      Isoleucine200
      Leucine370
      Lysine320
      Methionine81
      Cysteine64
      Phenylalanine147
      Tyrosine140
      Threonine210
      Tryptophan61
      Valine210
      NONESSENTIAL AMINO ACIDS
      mg/100 Calmg/100 g Pwd
      Arginine105
      Alanine154
      Aspartic Acid340
      Glutamic Acid700
      Glycine70
      Proline280
      Serine200
      Tyrosine140
      Threonine210
      Tryptophan61
      Valine210
  • Preparation of Feedings
    • Ready-to-use

      6 fl oz Bottles

      1. Wash hands thoroughly with soap and water before preparing bottle for

        feeding.
      2. SHAKE BOTTLE WELL and remove cap.
      3. Attach nipple unit (not included).

      NOTE: Although nutrient amounts per 100 Calories remain unchanged, diluting Enfaport with water results in lower nutrient amounts per fluid ounce (see MeadJohnson.com/pediatrics). Consult a doctor about the need to dilute Enfaport and for appropriate feeding volumes.

      WARNING: Do not use a microwave oven to warm formula. Serious burns may result.

      Failure to follow these instructions could result in severe harm.

      Opened bottles and prepared formula can spoil quickly. Either feed immediately or replace cap and store in refrigerator at 35–40°F (2–4°C) for no longer than 24 hours. Do not use opened bottle if it is unrefrigerated for more than a total of 2 hours. Do not freeze. After feeding begins, use formula within 1 hour or discard.

      See the chart below if the baby’s doctor recommends one of the following caloric densities:

      Indicated Cal/fl oz

      Water to add to 6 fl oz (177 mL) Enfaport

      Formula Yield

      20

      3.0 fl oz (89 mL)

      9.0 fl oz (266 mL)

      22

      2.2 fl oz (64 mL)

      8.2 fl oz (241 mL)

      24

      1.5 fl oz (44 mL)

      7.5 fl oz (221 mL)

      26

      0.9 fl oz (27 mL)

      6.9 fl oz (204 mL)

      27

      0.7 fl oz (20 mL)

      6.7 fl oz (197 mL)

      28

      0.4 fl oz (13 mL)

      6.4 fl oz (190 mL)

      Indicated Cal/fl oz

      Water to add to 6 fl oz (177 mL) Enfaport

      Volume for 100 Calories

      20

      3.0 fl oz (89 mL)

      5.0 fl oz (148 mL)

      22

      2.2 fl oz (64 mL)

      4.5 fl oz (134 mL)

      24

      1.5 fl oz (44 mL)

      4.2 fl oz (123 mL)

      26

      0.9 fl oz (27 mL)

      3.8 fl oz (114 mL)

      27

      0.7 fl oz (20 mL)

      3.7 fl oz (110 mL)

      28

      0.4 fl oz (13 mL)

      3.6 fl oz (106 mL)

  • References
      1. Kunz C, Lönnerdal B. Re-evaluation of the whey protein/casein ratio of human milk. Acta Paediatr. 1992;81:107-112.
      2. Birch EE, Hoffman DR, Uauy R et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209.
      3. Birch EE, Garfield S, Hoffman DR, et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.
      4. Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr. 2002;75:570-580.
      5. Hoffman DR, Birch EE, Castañeda YS, et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142:669-677.
      6. Hoffman DR, Birch EE, Castañeda YS, et al. Maturation of visual and mental function in 18-month-old infants receiving dietary long-chain polyunsaturated fatty acids (LCPUFAs) [abstract]. FASEB J. 2003;17:A727-A728. Abstract 445.1.
      7. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.
      8. Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mos. Am J Clin Nutr. 2005;81:871-879.
      9. Morale SE, Hoffman DR, Castañeda YS, et al. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197-203.
      10. Fomon SJ, Ziegler EE. Renal solute load and potential renal solute load in infancy. J Pediatr. 1999;134:11-14.
  • Consumer Reviews